Identification of pathogenesis-related microRNAs in hepatocellular carcinoma by expression profiling

El-Serag, 2007, Hepatocellular carcinoma: epidemiology and molecular carcinogenesis, Gastroenterology, 132, 2557, 10.1053/j.gastro.2007.04.061

Blum, 2005, Hepatocellular carcinoma: therapy and prevention, World J Gastroenterol, 11, 7391

Cramp, 1999, HBV + HCV = HCC?, Gut, 45, 168, 10.1136/gut.45.2.168

Soini, 1996, An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico, Carcinogenesis, 17, 1007, 10.1093/carcin/17.5.1007

Boffetta, 2003, Meta-analysis of studies of occupational exposure to vinyl chloride in relation to cancer mortality, Scand J Work Environ Health, 29, 220, 10.5271/sjweh.725

Tsukuma, 1995, A case-control study of hepatocellular carcinoma in Osaka, Japan, Int J Cancer, 45, 231, 10.1002/ijc.2910450205

Donato, 2002, Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women, Am J Epidemiol, 155, 323, 10.1093/aje/155.4.323

Volinia, 2006, A microRNA expression signature of human solid tumors defines cancer gene targets, Proc Natl Acad Sci USA, 103, 2257, 10.1073/pnas.0510565103

Yanaihara, 2006, Unique micro RNA molecular profiles in lung cancer diagnosis and prognosis, Cancer Cell, 9, 189, 10.1016/j.ccr.2006.01.025

Lee, 2007, Expression profiling identifies microRNA signature in pancreatic cancer, Int J Cancer, 120, 1046, 10.1002/ijc.22394

Murakami, 2006, Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues, Oncogene, 25, 2537, 10.1038/sj.onc.1209283

Budhu, 2008, Identification of metastasis-related microRNAs in hepatocellular carcinoma, Hepatology, 47, 897, 10.1002/hep.22160

Varnhort, 2008, MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma, Hepatology, 47, 1223, 10.1002/hep.22158

Laderio, 2008, MicroRNA profiling in hepatocellular tumor is associated with clinical features and oncogene/tumor suppressors gene mutations, Hepatology, 47, 1955, 10.1002/hep.22256

Li, 2008, Diagnostic and prognositic implications of microRNAs in human hepatocellular carcinoma, Int J Cancer, 123, 1616, 10.1002/ijc.23693

Ura, 2009, Differential microRNA expression between hapatitis B and hepatitis C leading disease progression to hepatocellular carcinoma, Hepatology, 49, 1098, 10.1002/hep.22749

Toffanin, 2011, MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a, Gastoenterology, 140, 1618, 10.1053/j.gastro.2011.02.009

Yasen, 2009, Expression of Aurora B and alterative variant forms in hepatocellular carcinoma and adjacent tissue, Cancer Sci, 100, 472, 10.1111/j.1349-7006.2008.01068.x

Gramantieri, 2008, MicroRNA involvement in hepatocellular carcinoma, J Cell Mol Med, 12, 2189, 10.1111/j.1582-4934.2008.00533.x

Aravalli, 2008, Molecular mechanisms of hepatocellular carcinoma, Hepatology, 48, 2047, 10.1002/hep.22580

Ji, 2009, New kids on the block, Cancer Biol Therapy, 8, 1683, 10.4161/cbt.8.18.8898

Liang, 2010, MicroRNA-125b suppressed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B, Hepatology, 52, 1731, 10.1002/hep.23904

Osaki, 2008, MicroRNAs as biomarkers and therapeutic drugs in human cancer, Biomarkers, 13, 658, 10.1080/13547500802646572

Takamizawa, 2004, Reduced expression of the let-7 micro RNAs in human lung cancers in association with shortened postoperative survival, Cancer Res, 64, 3753, 10.1158/0008-5472.CAN-04-0637

Fabbri, 2007, MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B, Proc Natl Acad Sci USA, 104, 15805, 10.1073/pnas.0707628104

Bommer, 2007, p53-mediated activation of miRNA34 candidate tumor-suppressor genes, Curr Biol, 17, 1298, 10.1016/j.cub.2007.06.068

Crawford, 2008, MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines, Biochem Biophys Res Commun, 373, 607, 10.1016/j.bbrc.2008.06.090

Hayashita, 2005, A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation, Cancer Res, 65, 9628, 10.1158/0008-5472.CAN-05-2352

Volinia, 2006, A microRNA expression signature of human solid tumors defines cancer gene targets, Proc Natl Acad Sci USA, 103, 2257, 10.1073/pnas.0510565103

Garofalo, 2008, MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer, Oncogene, 27, 3845, 10.1038/onc.2008.6

Yanaihara, 2006, Unique microRNA molecular profiles in lung cancer diagnosis and prognosis, Cancer Cell, 9, 189, 10.1016/j.ccr.2006.01.025

Hu, 2008, Genetic variants of miRNA sequences and non-small cell lung cancer survival, J Clin Invest, 118, 2600

Yu, 2008, MicroRNA signature predicts survival and relapse in lung cancer, Cancer Cell, 13, 48, 10.1016/j.ccr.2007.12.008

Markou, 2008, Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR, Clin Chem, 54, 1696, 10.1373/clinchem.2007.101741

Yan, 2008, MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis, RNA, 14, 2348, 10.1261/rna.1034808

Chan, 2008, miR-21 microRNA expression in human gastric carcinomas and its clinical association, Anticancer Res, 28, 907

Schepeler, 2008, Diagnostic and prognostic microRNAs in stage II colon cancer, Cancer Res, 68, 6416, 10.1158/0008-5472.CAN-07-6110

Childs, 2009, Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma, Am J Pathol, 174, 736, 10.2353/ajpath.2009.080731

Roldo, 2006, MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior, J Clin Oncol, 24, 4677, 10.1200/JCO.2005.05.5194

Marcucci, 2008, MicroRNA expression in cytogenetically normal acute myeloid leukemia, N Engl J Med, 358, 1919, 10.1056/NEJMoa074256

Calin, 2005, A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia, N Engl J Med, 353, 1793, 10.1056/NEJMoa050995

Lu, 2007, Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis, Cancer Res, 67, 10117, 10.1158/0008-5472.CAN-07-2544

Guo, 2008, Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma, Cancer Res, 68, 26, 10.1158/0008-5472.CAN-06-4418

Chim, 2008, Detection and characterization of placental microRNAs in material plasma, Clin Chem, 54, 482, 10.1373/clinchem.2007.097972

Gilad, 2008, Serum microRNAs are promising biomarkers, PLoS One, 3, e3148, 10.1371/journal.pone.0003148

Mitchel, 2008, Circulating microRNAs as stable blood-based markers for cancer detection, Proc Natl Acad Sci USA, 105, 10513, 10.1073/pnas.0804549105

Lawrie, 2008, Aberrant expression of microRNA biosynthetic pathways components is a common feature of haematological malignancy, Br J Hematol, 141, 672, 10.1111/j.1365-2141.2008.07077.x

Diaz, 2008, Deregulated expression of miR-106a predicts survival in human colon cancer patients, Genes Chromosomes Cancer, 47, 794, 10.1002/gcc.20580

Schee, 2010, MicroRNAs as biomarkers in colorectal cancer, Am J Patho, 177, 1592, 10.2353/ajpath.2010.100024

Wu, 2010, MicroRNA dysregulation in gastric cancer: a new player enters the game, Oncogene, 29, 5761, 10.1038/onc.2010.352

Zavadil, 2010, Profiling and functional analyses of microRNAs and their target gene products in human uterine leiomyomas, PLoS One, 5, e12362, 10.1371/journal.pone.0012362

Iorio, 2010, Interplay between microRNAs and the epigenetic machinery: an intricate network, Boichim Biophys Acta, 1799, 694, 10.1016/j.bbagrm.2010.05.005

Valeri, 2009, Epigenetics, miRNAs, and human cancer: a new chapter in human gene regulation, Mamm Genome, 20, 573, 10.1007/s00335-009-9206-5

Schaefer, 2010, MicroRNAs and cancer: current state and future perspectives in urologic oncology, Urologic Oncol, 28, 4, 10.1016/j.urolonc.2008.10.021

Garzon, 2010, Targeting microRNAs in cancer: rationale, strategies and challenges, Nat Rev Drug Discov, 9, 775, 10.1038/nrd3179

Calin, 2004, MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias, Proc Natl Acad Sci USA, 101, 11755, 10.1073/pnas.0404432101

Betel, 2010, Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites, Genome Biol, 11, R90, 10.1186/gb-2010-11-8-r90

Kang, 2008, Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer, Cancer Genet Cytogenet, 82, 1

Yamamoto, 2007, Gain of 5p15.33 is associated with progression of bladder cancer, Oncology, 72, 132, 10.1159/000111132

Yu, 2008, A precisely regulated gene expression cassette potentially modulates metastasis and survival in multiple solid cancers, PLoS Genet, 4, e1000129, 10.1371/journal.pgen.1000129

Bodmer, 2002, Disruption of a novel MFS transporter gene, DIRC2, by a familial renal cell carcinoma-associated t(2;3)(q35;q21), Hum Mol Genet, 11, 641, 10.1093/hmg/11.6.641

Watanabe, 2010, Expression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: a novel approach of correlating malignancy grade and prognosis, J Neurooncol, 100, 449, 10.1007/s11060-010-0201-1